Subtype
Infratentorial Neoplasm
CI-CAN-00005577Explore in graph →
Non-malignant110 active trials7 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005577Explore in graph →
Clinical trials
372 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00404495 | Combination of Irinotecan and Temozolomide in Children With Brain Tumors. | completed | Phase 2 | 83 | PfizerINDUSTRY | 8 | Apr 18, 2012 | clinicaltrials |
| NCT00036569 | A Phase II Study of Pegylated Interferon Alfa 2b (PEG-Intron(Trademark)) in Children With Diffuse Pontine Gliomas | completed | Phase 2 | 32 | National Cancer Institute (NCI)NIH | 1 | Feb 13, 2012 | clinicaltrials |
| NCT00600054 |
| Phase 2 Study of Nimotuzumab in Pediatric Recurrent Diffuse Intrinsic Pontine Glioma |
| completed |
| Phase 2 |
| 44 |
| YM BioSciencesINDUSTRY |
| 3 |
| Jul 6, 2011 |
| clinicaltrials |
| NCT00520936 | A Study of Pemetrexed in Children With Recurrent Cancer | completed | Phase 2 | 72 | Eli Lilly and CompanyINDUSTRY | 1 | Feb 25, 2011 | clinicaltrials |
| NCT00418327 | Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma | completed | Phase 1 | 48 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Aug 7, 2009 | clinicaltrials |
| NCT00001502 | A Pediatric Phase I Trial of RMP-7 and Carboplatin in Brain Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
Data updated 22 days agoSource updated Apr 18, 2012source: clinicaltrials